(4S)-4-benzyl-2-(3-pyridinyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo[4,5-d][1,3]diazepin-5-one | 1369585-34-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑二氮卓类
• 英文名称: (4S)-4-benzyl-2-(3-pyridinyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo[4,5-d][1,3]diazepin-5-one
• 英文别名: (13S)-13-benzyl-11-pyridin-3-yl-2,8,10,12-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7,11-pentaen-14-one
• CAS: 1369585-34-1
• 化学式: C₂₂H₁₇N₅O
• 分子量: 367.41
• InChiKey: BSCZBLPZGWBSSH-KRWDZBQOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  28
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  71.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  咪唑并[1,2-a]吡啶-2-胺 在 盐酸 、 碘 、 lead(IV) tetraacetate 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 、 氯仿 、 水 为溶剂， 反应 11.0h， 生成 (4S)-4-benzyl-2-(3-pyridinyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo[4,5-d][1,3]diazepin-5-one
  参考文献：
  名称：

  2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应：在咪唑并吡啶[1,3]二氮杂吡啶酮类化合物的合成中的应用

  摘要：

  一系列20个光学纯的3,4-二氢-5 H-吡啶并[1'，2'：1,2]咪唑并[4,5- d ] [1,3]二氮杂-5-酮形成一个新家族分四步合成了氮杂杂环融合的[1,3]二氮杂ze，总产率为17-66％。关键步骤包括在C-3处容易获得的2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应。

  DOI：

  10.1021/jo300364d

文献信息

• Selective C-Acylation of 2-Aminoimidazo[1,2-<i>a</i>]pyridine: Application to the Synthesis of Imidazopyridine-Fused [1,3]Diazepinones
  作者：Nicolas Masurier、Roberta Aruta、Vincent Gaumet、Séverine Denoyelle、Emmanuel Moreau、Vincent Lisowski、Jean Martinez、Ludovic T. Maillard

  DOI：10.1021/jo300364d

  日期：2012.4.6

  2]imidazo[4,5-d][1,3]diazepin-5-ones which form a new family of azaheterocycle-fused [1,3]diazepines were synthesized in four steps with 17–66% overall yields. The key step consists of a selective C-acylation reaction of easily accessible 2-aminoimidazo[1,2-a]pyridine at C-3.

  一系列20个光学纯的3,4-二氢-5 H-吡啶并[1'，2'：1,2]咪唑并[4,5- d ] [1,3]二氮杂-5-酮形成一个新家族分四步合成了氮杂杂环融合的[1,3]二氮杂ze，总产率为17-66％。关键步骤包括在C-3处容易获得的2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应。
• Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
  作者：Dominique P. Arama、Feryel Soualmia、Vincent Lisowski、Jean-François Longevial、Elodie Bosc、Ludovic T. Maillard、Jean Martinez、Nicolas Masurier、Chahrazade El Amri

  DOI：10.1016/j.ejmech.2015.02.008

  日期：2015.3

  The human tissue kallikrein-7 (KLK7) is a chymotryptic serine protease member of tissue kallikrein family. KLK7 is involved in skin homeostasis and inflammation. Excess of KLK7 activity is also associated with tumor metastasis processes, especially in ovarian carcinomas, prostatic and pancreatic cancers. Development of Kallikrein 7 inhibitors is thus of great interest in oncology but also for treating skin diseases. Most of the developed synthetic inhibitors present several drawbacks such as poor selectivity and unsuitable physico-chemical properties for in vivo use. Recently, we described a practical sequence for the synthesis of imidazopyridine-fused [1,3]-diazepines. Here, we report the identification of pyrido-imidazodiazepinone core as a new potential scaffold to develop selective and competitive inhibitors of kallikrein-related peptidase 7. Structure-activity relationships (SAR), inhibition mechanisms and selectivity as well as cytotoxicity against selected cancer cell lines were investigated. (C) 2015 Elsevier Masson SAS. All rights reserved.